Overview

Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

Status:
Completed

Trial end date:
2016-02-29

Target enrollment:

Participant gender:

Summary

A Phase 3 Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

Phase:

Phase 3

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical

Treatments:

Amlodipine
Candesartan
Candesartan cilexetil